Registered Trials
-
NCT05069129
Phase 3United Arab Emirates
Total Enrollment: 1,848
Official Trial Registration:
-
NCT04869592
Phase 1/2China
Total Enrollment: 3,580
Official Trial Registration:
This site is no longer being updated. Data are accurate as of 2 Dec 2022.
© 2023 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.